Boston Scientific Corp (BSX)vsENvue Medical Inc. (FEED)
BSX
Boston Scientific Corp
$69.78
+2.39%
HEALTHCARE · Cap: $101.28B
FEED
ENvue Medical Inc.
$2.26
+58.04%
HEALTHCARE · Cap: $1.31M
Smart Verdict
WallStSmart Research — data-driven comparison
Boston Scientific Corp generates 747535% more annual revenue ($20.07B vs $2.69M). BSX leads profitability with a 14.4% profit margin vs -2.5%. BSX earns a higher WallStSmart Score of 63/100 (C+).
BSX
Buy63
out of 100
Grade: C+
FEED
Hold41
out of 100
Grade: D
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+1.2%
Fair Value
$70.62
Current Price
$69.78
$0.84 discount
Intrinsic value data unavailable for FEED.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Growing faster than its price suggests
15.9% revenue growth
Generating 1.0B in free cash flow
Reasonable price relative to book value
Revenue surging 92.0% year-over-year
Areas to Watch
Premium valuation, high expectations priced in
0.0% earnings growth
Smaller company, higher risk/reward
ROE of -30.5% — below average capital efficiency
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : BSX
The strongest argument for BSX centers on Market Cap, PEG Ratio, Revenue Growth. Revenue growth of 15.9% demonstrates continued momentum. PEG of 0.75 suggests the stock is reasonably priced for its growth.
Bull Case : FEED
The strongest argument for FEED centers on Price/Book, Revenue Growth. Revenue growth of 92.0% demonstrates continued momentum.
Bear Case : BSX
The primary concerns for BSX are P/E Ratio.
Bear Case : FEED
The primary concerns for FEED are EPS Growth, Market Cap, Return on Equity.
Key Dynamics to Monitor
BSX profiles as a growth stock while FEED is a hypergrowth play — different risk/reward profiles.
FEED carries more volatility with a beta of 2.28 — expect wider price swings.
FEED is growing revenue faster at 92.0% — sustainability is the question.
BSX generates stronger free cash flow (1.0B), providing more financial flexibility.
Bottom Line
BSX scores higher overall (63/100 vs 41/100) and 15.9% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Boston Scientific Corp
HEALTHCARE · MEDICAL DEVICES · USA
Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.
ENvue Medical Inc.
HEALTHCARE · MEDICAL DEVICES · USA
ENvue Medical Inc. (FEED) is a forward-thinking healthcare technology firm committed to revolutionizing patient care management through advanced medical devices and software solutions. By harnessing innovative technology, ENvue Medical focuses on optimizing recovery processes and improving health outcomes across various clinical settings. The company's robust product pipeline, coupled with strategic collaborations, positions it well to capitalize on the growth of the healthcare industry, presenting a compelling investment opportunity for institutional investors seeking exposure to the dynamic fields of medical device innovation and digital health advancements.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?